Answers are grounded in this paper and cite their sources.
Somatostatin analogues appear to decrease the duration of enterocutaneous fistulas and duration of hospital stay, but no mortality benefit was identified. The quality of evidence for outcomes in this review ranged from low to moderate. Future large, blinded, RCT would be useful in improving the confidence in the treatment effects identified in this systematic review and meta-analysis.
No takes yet. Share an insight, caveat, or question.
Coughlin et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: